nivolumab,ipilimumab,cabozantinib
bms,exelixis
['triplet,(-triplete)', 'rcc,(-irccs),(-srcc),(-urcc)', 'cosmic-313']
 great day for mrcc pts! don t forget a presidential symposium iii today #esmo22 will be presented a cosmic-313 ph3 study in mrcc! triplet vs doublet!! lead by a gur and great discussant super 
Medical Oncologist. Involved in GU tumors oncology. Adjunct Assoc. Professor UCM. Executive member SOGUG Foundation. Hospital Univ. 12 de Octubre. Madrid.